Drugs
Subcutaneous Semaglutide in Heart Failure and Obes
Subcutaneous Semaglutide in Heart Failure and Obesity

Weight loss drugs, such as subcutaneous semaglutide, benefit patients with heart failure and obesity, offering potential therapeutic options for improving cardiovascular health and metabolic outcomes in this population.

April 2024

Is it Time to Start Calling a Spade a Spade?
Is it Time to Start Calling a Spade a Spade?

Dissertation on the correct terminology of anticonvulsant drugs vs. antiepileptics, aiming to clarify and standardize terminology in the field of epilepsy treatment.

April 2024

Advise Against the Use of Aspirin in the First Pre
Advise Against the Use of Aspirin in the First Prevention of Stroke in Older People

A study on the use of low-dose aspirin in healthy older individuals found an increased risk of stroke and intracerebral hemorrhage, leading to recommendations against its use for primary stroke prevention in this population.

April 2024

Investigation of Multi-Resistant Bacteria in Commu
Investigation of Multi-Resistant Bacteria in Community Environments

NIH researchers are investigating multidrug-resistant Klebsiella pneumoniae in community environments, addressing the urgent need to understand and combat antibiotic resistance.

April 2024

Clinical Trial with a New Drug for Resistant Hyper
Clinical Trial with a New Drug for Resistant Hypertension

Details of the Target-HTN randomized clinical trial investigating the efficacy of aldosterone synthase inhibition with lorundrostat for uncontrolled hypertension, aiming to provide new therapeutic options for patients with resistant hypertension.

April 2024

Use of Aspirin for Secondary Prevention of Cardiov
Use of Aspirin for Secondary Prevention of Cardiovascular Diseases

There is suboptimal use of aspirin in many countries around the world for secondary prevention of cardiovascular diseases, indicating a gap between evidence-based recommendations and clinical practice.

April 2024

Aspirin After a Heart Attack is Mandatory
Aspirin After a Heart Attack is Mandatory

Aspirin is mandated after a heart attack due to its ability to prevent the formation of blood clots and reduce the risk of recurrent myocardial infarction or stroke, emphasizing its critical role in secondary prevention.

April 2024

Synthetic Antibiotic Could Be Effective Against Re
Synthetic Antibiotic Could Be Effective Against Resistant Superbugs

Duke researchers have developed a new synthetic antibiotic that shows promise against drug-resistant superbugs, offering potential solutions to combat the growing threat of antibiotic resistance.

April 2024

Janus Kinase (JAK) Inhibitors for Alopecia Areata
Janus Kinase (JAK) Inhibitors for Alopecia Areata

Baricitinib and ritlecitinib are the first two drugs approved for severe alopecia areata, offering new treatment options for this challenging autoimmune condition affecting hair follicles.

March 2024

Annual Overdose Deaths in the US Surpass 109,000
Annual Overdose Deaths in the US Surpass 109,000

With a 0.7% increase from the previous year, the surge in overdose deaths in the US is attributed to the availability of lethal drugs like fentanyl.

March 2024

Allergies Artificial Intelligence Cancer Cardiovascular Child care Covid Diabetes Drugs Exercising Food & Health Hypertension Microbiology Neurology Obstetrics Ophtalmology Oral health Respiratory Skin care Sleep Smoking Surgery Vaccines Women's health
Top reads...
Reevaluating Sunlight Exposure New Study Unveils Effective TB Prevention Strategy Smoking, Alcohol Consumption, and Risk of Incident Diverticulitis Rotator cuff surgery Differences in the Top 20 Causes of Illness Between Men and Women